Naar homepage     
Chronische Cerebro-Spinale Veneuze Insufficiëntie
Aanmelden op het CCSVI.nl forum 		Lees Voor (ReadSpeaker)    A-   A+
Over CCSVI.nl | Zoeken | Contact | Forum
CCSVI.nl is onderdeel van de
Franz Schelling Website
meer informatie
  
›Alemtuzumab (Lemtrada) licence turned down in US
Saturday, January 4, 2014 11:08 PM | Tony Miles Volg link

›Alemtuzumab (Lemtrada) licence turned down in US

30 December 2013


Author:


The FDA has turned down the licence application for alemtuzumab in the US citing lack of evidence that the benefits outweigh its serious adverse effects. The manufacturer, Genzyme, intends to appeal. The drug is licensed in Europe and is currently being appraised by NICE.